Nectar Lifesciences Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
NECLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Nectar Lifesciences has submitted to the exchanges a quarterly certificate from its Registrar and Share Transfer Agent, Kfin Technologies Limited, for the quarter ended December 31, 2025. The certificate confirms that all securities received from depository participants for dematerialization during the quarter were properly verified and confirmed with the depositories. It also confirms that accepted physical certificates were mutilated and cancelled, and the names of depositories were substituted as registered owners in the member register within the prescribed timelines. The certificate has been submitted to both NSE and BSE, where the company's shares are listed under symbol NECLIFE (NSE) and scrip code 532649 (BSE).
This is a routine quarterly compliance filing required under SEBI's Depository Regulations and has no direct impact on the company's operations, financials, or share price. Investors can treat this as standard housekeeping confirming proper handling of share dematerialization requests.